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Biosensors relying on the fluorescence reso-
nance energy transfer (FRET) between fluo-
rescent proteins have been used for live-cell
imaging of cellular events including Ca2+ signal-
ing. The efficiency of energy transfer between
the donor and acceptor fluorescent proteins
depends on the relative distance and orienta-
tion between them, which become altered by
conformational changes of a fused sensory pro-
tein caused by a cellular event. In this way,
changes in FRET efficiency of Ca2+ biosensors
can be correlated with Ca2+ concentrations.
The design of these FRET biosensors can be
improved by modeling conformational changes
before and after a cellular event. Hence, a com-
putational tool called FPMODwas developed to
predict FRET efficiency changes by construct-
ing FRET biosensors and sampling their confor-
mational space through rigid-body rotation. We
showed with FPMOD that our computational
modeling approach can qualitatively predict
the FRET efficiencies of a range of biosensors,
which had strong agreement with experimental
results.
Introduction
Fluorescence resonance energy transfer (FRET) biosen-
sors have become invaluable tools for the live-cell imaging
of many cellular events such as caspase activation, pro-
tein phosphorylation, and Ca2+ signaling (Griesbeck,
2004; Miyawaki, 2003; Pozzan et al., 2003; Truong and
Ikura, 2001). FRET is the natural phenomenon of energy
transfer via resonance between two fluorophores with
a spectral overlap between the donor emission and the
acceptor excitation. The efficiency of this energy transfer
dynamically responds to the relative distance and orienta-
tion between the donor and acceptor (Clegg, 1995). In
FRET biosensors, natural sensory proteins for the desired
cellular events are inter- or intramolecularly fused withStructure 15,a pair of fluorescent proteins suitable for FRET, such as
cyan fluorescent protein (CFP) as the donor and yellow
fluorescent protein (YFP) as the acceptor (Li et al., 2006;
Tsien, 1998). The conformational change of the sensory
protein caused by the cellular event alters the distance
and orientation of the fluorescent proteins. Hence,
a change in FRET efficiency of the biosensor is correlated
with the cellular event. For example, FRET Ca2+ bio-
sensors have been designed that correlate Ca2+ concen-
tration levels with FRET efficiency changes between CFP
and YFP genetically fused with Calmodulin (CaM), a cyto-
plasmic Ca2+-sensitive protein (Berridge et al., 2000;
Miyawaki et al., 1997, 1999). Upon binding Ca2+ ions,
CaM undergoes a conformational change from an ex-
tended to a more compact conformation by wrapping
around a CaM-binding peptide such as that from myosin
light chain kinase (MLCKp) (Kuboniwa et al., 1995;
Wriggers et al., 1998). This conformational change alters
the relative distance and orientation of the fluorescent
proteins. As a result, an increase in FRET efficiency is
correlated with a higher Ca2+ concentration. By observing
the change in fluorescence intensity of the acceptor YFP,
the onset and termination of localized Ca2+ signaling can
be detected. To accurately distinguish signal from noise,
these biosensors often need a large dynamic range, which
is defined as the division of the maximum emission ratio
(Rmax) by the minimum emission ratio (Rmin), where the
emission ratio is the quotient of the acceptor emission
peak to the donor emission peak. One common approach
to improving dynamic range is by using variants of CFP
and YFP that have more favorable properties for FRET
such as Cerulean, Citrine, Venus, and circularly permu-
tated fluorescent proteins (Griesbeck et al., 2001; Miya-
waki et al., 1999; Nagai et al., 2002; Rekas et al., 2002).
The design of FRET biosensors can be improved by
modeling their conformational changes before and after
activation by a cellular event. For example, a FRET Ca2+
biosensor with an improved dynamic range was rationally
designed based on the NMR structure of CaM bound to
the CaM-binding peptide from CaM-dependent kinase
kinase (CKKp) (Truong et al., 2001). The computational
model of the CaM and CKKp complex showed that CKKp
could be spliced within the hinge of CaM. This allowed for515–523, May 2007 ª2007 Elsevier Ltd All rights reserved 515
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the Ca2+-bound form of the biosensor, resulting in a higher
Rmax and, thus, a larger dynamic range. In another exam-
ple, the dynamic range of a caspase-3 activation biosen-
sor was improved by computational modeling based on
the solved atomic structure of caspase-3 bound to its tet-
rapeptide inhibitor (Xu et al., 1998). Caspase-3 proteolytic
cleavage of its specific target sequences within substrate
proteins is a key activating event of apoptosis. To image
caspase-3 activation in living cells, a biosensor can be
constructed consisting of a fusion of a CFP donor, a spe-
cific cleavage recognition sequence, and a YFP acceptor.
Computational modeling showed that the optimal linker
length of a caspase-3 activation biosensor was 20 amino
acid residues (Chiang and Truong, 2006). The optimization
of this linker length produced a biosensor with a greater
dynamic range for both in vitro and in vivo studies. These
examples demonstrate the effectiveness of designing
a FRET biosensor by studying its conformational changes.
Hence, in this paper, we describe a computational tool
called FPMOD (Fusion Protein Modeler; available
at http://individual.utoronto.ca/ktruong/software.htm) to
construct FRET biosensors and sample conformational
spaces for the purpose of predicting FRET efficiency
changes. FPMOD consists of a set of programs used to
generate fusion protein constructs from PDB files, to de-
fine regions of flexible linkers between domains, and to
produce random conformations by rotation of domains
around these flexible linkers. For each conformation gen-
erated, the distance and orientation factors, as well as
FRET efficiencies, are then calculated. A tabulation of
these values can be used to predict FRET changes of bio-
sensor designs. To demonstrate the feasibility of FPMOD,
it was used to predict FRET efficiency changes, as well
as corresponding emission-ratio changes, which had
a strong agreement with experimental results, of several
FRET Ca2+ biosensors. Changes in FRET signals for ten
different experimentally generated biosensor constructs
were determined. In all cases, qualitative predictions of
the FRET signal decrease or increase agreed with exper-
imental findings.
Results and Discussion
Understanding the conformational space conferred by
flexible linkers is important for predicting the FRET effi-
ciency changes of biosensors in response to a stimulus.
We introduced a modeling tool called FPMOD that is ca-
pable of constructing fusion proteins given solved atomic
structures of the individual protein domains. More impor-
tantly, FPMOD was used to sample the conformational
space of these fusion proteins by treating each domain
as a rigid body and rotating the domains with respect to
their flexible linkers. The dihedral angles c and 4 take on
random values, and conformations that do not sterically
collide after random rotations of the linker regions are ac-
cepted. With this approximation, no preferences are given
to particular dihedral angles or any potentially favorable
packing of rigid domains. It is possible that using a gradi-
ent of linker flexibility may provide a better correlation be-516 Structure 15, 515–523, May 2007 ª2007 Elsevier Ltd All rigtween simulated and experimental results by eliminating
certain less favorable conformations. However, for sim-
plicity, in FPMOD, the intervening linker regions between
user-defined boundaries are given complete flexibility.
Surprisingly, even with these relatively crude approxima-
tions, it was sufficient to detect a qualitative correlation
between simulation and experimental results.
Besides approximations incorporated into the simula-
tion process, possible sources of error exist for the exper-
imental values obtained. Photobleaching of fluorophores,
protein degradation, and autofluorescence interfering with
spectral data are common concerns. In addition, fluoro-
phore properties may be altered when they are part of
fusion proteins. While these experimental sources of error
were not significant enough to prevent a qualitative corre-
lation, they may contribute to discrepancies between
quantitative comparisons.
The Relationship between the Changes in FRET
Efficiency and FRET Emission Ratio
FRET efficiency changes are interpreted differently in the
context of simulations versus experimental data. In simu-
lating biosensor models, a change in FRET efficiency is
simply the percentage increase or decrease in FRET effi-
ciency values between two cases. However, experimen-
tally, a change in FRET efficiency is evident as a change
in emission spectra such that the emission ratio of YFP
to CFP can be calculated. Thus, a means of estimating
emission ratio from FRET efficiency has been developed
(see Experimental Procedures) to translate FRET effi-
ciency values found through simulation into emission
ratios to allow for the direct comparison between theoret-
ical and experimental results. In addition, the qualitative
changes also serve as a means of comparison between
these two sets of data in which an increase in FRET effi-
ciency would be apparent in in vitro studies as an increase
in the FRET emission ratio of YFP to CFP. Using this qual-
itative comparison, simulation results of FRET efficiency
predictions were found to be consistent with in vitro ex-
perimental data in all tested cases (Table 1).
Ca2+ Biosensors Based on the CaM-MLCKp
or CaM-CKKp Complex Show Both an Increase
and Decrease, Respectively, in FRET Efficiency
Recently, we designed two CaM-based biosensors
(named YCKKpC-CaM and YMLCKpC-CaM), and com-
putational modeling with FPMOD showed that the FRET
efficiency for YCKKpC-CaM should decrease, while that
for YMLCKpC-CaM should increase, upon Ca2+ binding.
The structural diversity of CaM-peptide binding was
used to design two biosensors to measure Ca2+-concen-
tration changes in living cells. FPMOD simulation results
predicted that the FRET efficiency for both biosensors
would be similar in the unbound case, but suggested
that while FRET efficiency would increase for YMLCKpC-
CaM upon binding of Ca2+ from 17% to 32%, it would
decrease for YCKKpC-CaM from 20% to 7.6%. This cor-
responds to a predicted emission-ratio increase of 45%
and a decrease of 26%. Although in both cases CaM un-
dergoes conformational changes upon Ca2+ induction,
the resulting complexes are different (Figure 1). First, therehts reserved
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Ways & MeansTable 1. Tabulation of the Distance Factor, Orientation Factor, and FRET Efficiency Values Predicted by FPMOD
Simulation
Distancea (A˚) k2 E% Sim EmR Exp EmR Sim EmR Change (%) Exp EmR Change (%)
Predicted Biosensor Cases
YMLCKpC-CaM (unbound) 65 ± 13 0.77 17 1.07 1.5 — —
YMLCKpC-CaM (bound) 50 ± 8.1 0.55 32 1.55 2.2 45 47
YCKKpC-CaM (unbound) 61 ± 15 0.64 20 1.15 2.1 — —
YCKKpC-CaM (bound) 72 ± 13 0.40 7.6 0.85 1.7 26 19
YC21 (unbound) 75 ± 15 0.69 7.1 0.84 1.1 — —
YC21 (bound) 75 ± 15 0.77 9.4 0.89 1.6 5.9 45
YC61 (unbound) 76 ± 15 0.59 6.9 0.83 1.1 — —
YC61 (bound) 69 ± 15 0.70 12 0.95 2.3 14 109
CEcadY12 (unbound) 91 ± 21 0.59 3.1 0.76 0.81 — —
CEcadY12 (bound) 85 ± 20 0.39 4.5 0.79 0.92 3.6 14
Predicted cpVenus Biosensor Cases
cp49Venus (bound) 77 ± 13 0.76 7.2 0.84 1.4 0.25 0
cp157Venus (bound) 74 ± 14 0.86 9.5 0.89 2.8 6.2 158
cp173Venus (bound) 75 ± 18 0.82 11 0.92 4.3 10 210
cp195Venus (bound) 76 ± 17 0.90 8.3 0.86 2.4 3.0 102
cp229Venus (bound) 77 ± 13 0.76 7.3 0.85 1.75 1.3 75
cp58Venus (bound) 78 ± 19 0.51 9.8 0.88 — 4.9 —
cp116Venus (bound) 76 ± 15 0.90 7.5 0.85 — 1.0 —
cp135Venus (bound) 78 ± 15 0.59 7.4 0.84 — 0.75 —
cp145Venus (bound) 73 ± 15 0.69 8.4 0.87 — 3.3 —
cp215Venus (bound) 75 ± 14 0.67 9.1 0.88 — 5.1 —
a Errors provided for the distance factors calculated correspond to standard deviations of a sample with 130 models. Errors are not
provided for the orientation factor and FRET efficiency values because they display non-Gaussian distributions.is a structural difference between the target peptides
when in complex with CaM, where MLCKp adopts an
a-helical conformation and CKKp forms an a helix with
a hairpin-like loop folded back onto the a helix. Second,
the peptides bind to CaM in opposite orientations (Ikura
et al., 1992; Osawa et al., 1999). Due to these differences,
the direction of FRET efficiency change is different be-
tween the two biosensor constructs. In fact, in vitro exper-
imental data confirmed the predicted direction of change,
whether increasing or decreasing, showing an emission-
ratio increase of 47% for YMLCKpC-CaM and a decrease
of 19% for YCKKpC-CaM (Figures 2 and 3). Furthermore,
simulation results predicted that unbound FRET effi-
ciencies of YMLCKpC-CaM and YCKKpC-CaM are higher
than that of YC2.1, with efficiency values of 17% and 20%,
respectively, versus 7.1% (Table 1). These constructs
have higher FRET efficiencies because the distance is
closer structurally (65 A˚ for YMLCKpC-CaM and 61 A˚ for
YCKKpC-CaM versus 75 A˚ for YC2.1). This prediction is
consistent with experimental findings. The biosensors dis-
play both an increase and decrease in distance factor, but
both show a decrease in orientation factor. Since the
direction of efficiency change correlates with that ofStructure 15,distance change, the distance factor is the dominant
influence in these biosensors.
The YC6.1 Ca2+ Biosensor Has a Larger Dynamic
Range Than YC2.1
FPMOD also confirmed that the YC6.1 biosensor does in-
deed have a higher FRET efficiency than YC2.1. YC6.1
was previously designed based on the NMR structure of
CaM bound to CKKp (Osawa et al., 1999) and was seen
to display a 2-fold increase in the FRET dynamic range
(Truong et al., 2001). Studies have shown that CaM binds
to different target peptides through different mechanisms
and interactions. Specifically, CaM binds to peptides
MLCKp and CKKp in the presence of Ca2+ (Ikura et al.,
1992; Osawa et al., 1999). YC2.1 was designed based
on the structural information for CaM bound to MLCKp
and consisted of the traditional tandem fusion of CFP,
CaM, MLCKp, and YFP. However, structural studies of
CaM bound to CKKp suggested an innovative design for
a new biosensor (Truong et al., 2001). The unique binding
of CaM to CKKp and the orientation of the peptide with
respect to the two CaM domains suggested that CKKp
could replace a linker region within the CaM protein itself.
Thus, YC6.1, consisting of a tandem fusion of CFP, the515–523, May 2007 ª2007 Elsevier Ltd All rights reserved 517
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Ways & MeansFigure 1. Superposition of Multiple Conformations of the YMLCKpC-CaM and YCKKpC-CaM Biosensors in the Presence and
Absence of Ca2+ Binding
(A–D) Superposition of possible conformations for the YMLCKpC-CaM biosensor (A) before and (B) after Ca2+ binding and for the YCKKpC-CaM
biosensor (C) before and (D) after Ca2+ binding. Before Ca2+ binding, conformations are in the unbound state and models are aligned with CaM; after
Ca2+ binding, conformations are in the bound state and models are aligned with the CaM-peptide complex. Several conformations are highlighted for
emphasis with CaM (orange), YFP (yellow), CFP (cyan), and CaM-binding peptide (red).N-terminal fragment of CaM (N-CaM), CKKp as the linker
region, the C-terminal fragment of CaM (C-CaM), and
YFP, was constructed (Truong et al., 2001). It was as-
sumed that the unbound forms of YC2.1 and YC6.1 would
be separated by a similar distance and would thus have
similar FRET efficiencies, but it was expected that YC6.1
would display a greater dynamic range since it would al-
low for a closer interaction, and thus a shorter distance,
in the CaM-CKKp complex than the CaM-MLCKp com-
plex of YC2.1. FPMOD confirmed that YC6.1 had a higher
FRET efficiency change upon Ca2+ induction than YC2.1
(6.9% to 12% versus 7.1% to 9.4%), which corresponds
to increases in emission ratios of 14% versus 5.9%. This
is qualitatively consistent with in vitro data, which in-
dicated emission-ratio increases of 109% and 45% for518 Structure 15, 515–523, May 2007 ª2007 Elsevier Ltd All righYC6.1 and YC2.1, respectively (Truong et al., 2001).
FPMOD results also confirmed that while the unbound dis-
tances were similar between YC6.1 and YC2.1 (76 A˚ ver-
sus 75 A˚), YC6.1 was indeed a more compact complex
with a shorter distance between CFP and YFP in the
bound case than YC2.1 (69 A˚ versus 75 A˚). The successful
design of YC6.1 resulted in an improved dynamic range
over that for YC2.1 and demonstrated the advantages
of rational biosensor design. More importantly, the consis-
tent results found from FPMOD simulation results with
previous experimental data for YC2.1 and YC6.1 demon-
strate that with the aid of computational modeling, poten-
tial biosensor candidates can be rationally designed and
assessed through simulations prior to labor-intensive
and time-consuming experimental studies.ts reserved
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Ways & MeansFigure 2. Emission Spectra of
the YMLCKpC-CaM, YCKKpC-CaM,
CEcadY12, and CEcadY23 Biosensors
in the Presence and Absence of Ca2+
Binding
(A–D) Emission spectra for (A) YMLCKpC-
CaM, (B) YCKKpC-CaM, (C) CEcadY12, and
(D) CEcadY23 in Ca2+-free (gray) and Ca2+-
saturating (black) conditions.Certain YC2.1 Ca2+ Biosensors with Different
Circularly Permutated Venus, cpVenus, Acceptors
Can Have Dramatic FRET Efficiency Changes
By computational modeling of YC2.1 biosensors with
cpVenus acceptors, FPMOD also confirmed that FRET
efficiency changes are highly sensitive to relative spatial
orientation. Circularly permutated proteins have been
used to improve the dynamic range of FRET biosensors
(Nagai et al., 2001, 2004; Nakai et al., 2001; Tallini et al.,Structure 152006). Nagai et al. used the YC2.1 biosensor as a template
to optimize the relative orientation of the two fluorophores
and their associated transition dipoles by fusing YFP at
different angles. In addition to the original N terminus at
residue Met1, new N termini were positioned at different
sites on the b barrel, specifically at Thr49, Gln157,
Asp173, Leu195, and Ile229. One of their constructs
showed an increase in the emission ratio of Venus to
CFP by nearly 600% with the saturation of Ca2+. ThisFigure 3. Histograms of the Distance
Factor, Orientation Factor, and FRET
Efficiency for YMLCKpC-CaM and
YCKKpC-CaM
(A–L) Histogram results for the distance factor,
orientation factor, and FRET efficiency pre-
dictions from FPMOD simulation for (A–C)
YMLCKpC-CaM in the absence of Ca2+, (D–F)
YMLCKpC-CaM after Ca2+ binding, (G–I)
YCKKpC-CaM in the absence of Ca2+, and
(K–L) YCKKpC-CaM after Ca2+ binding for
130 models generated. In all cases, the star
indicates E% values greater than 37.5%., 515–523, May 2007 ª2007 Elsevier Ltd All rights reserved 519
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resolution imaging of subcellular Ca2+ changes in both
cultured cells and in cells in the nervous system of trans-
genic mice (Nagai et al., 2004). It was found experimen-
tally that different cpVenus acceptors displayed different
emission-ratio changes, listed in descending order, in
the presence of Ca2+: cp173Venus (210%), cp157Venus
(158%), original YC2.1 (122%), cp195Venus (102%),
cp229Venus (75%), and cp49Venus (0%). FPMOD con-
firmed that the unbound FRET efficiencies of these
biosensors were similar to those of YC2.1, because in
the absence of Ca2+, the domains have complete rota-
tional freedom (data not shown). Furthermore, our FPMOD
simulation results were consistent with the relative order
of emission-ratio improvements (Table 1): cp173Venus
(10%), cp157Venus (6.2%), original YC2.1 (5.9%),
cp195Venus (3.0%), cp229Venus (1.3%), and cp49Venus
(0.25%). In particular, simulation results confirmed that in-
corporating cp173Venus, rather than the other constructs,
into the biosensor results in a significantly better improve-
ment in FRET efficiency, and that incorporating the
cp49Venus construct results in only a slight response
to Ca2+. When other cpVenus acceptors (cp58Venus,
cp116Venus, cp135Venus, cp145Venus, and cp215Venus)
were tested, several acceptors, namely, cp215Venus
(5.1%), cp58Venus (4.9%), and cp145Venus (3.3%) dem-
onstrated relatively good emission-ratio increases. Thus,
these cpVenus acceptors might be good candidates for
further experimental studies. The agreement between
FPMOD simulation results and experimental data here in-
dicates that FPMOD is versatile enough to improve dy-
namic range through the optimization of both distance
and orientation factors of biosensors based on the Ca2+-
binding properties of the cytoplasmic CaM protein.
Ca2+ Biosensors Based on the Extracellular
Epithelial Cadherin, Ecad, Repeats Show an
Increase in FRET Efficiency after Binding to Ca2+
A common shortcoming of biosensor constructs based on
CaM as the Ca2+-sensing component is their susceptibility
to binding of endogenous CaM proteins to peptide re-
gions, thus perturbing biosensor sensitivity to Ca2+
changes in vivo. For the same reason, there has been a
concern that CaM-based biosensors may interfere with
CaM signaling in cells (Heim and Griesbeck, 2004). One
means of addressing these concerns is to reengineer the
binding interface between CaM and the target peptide to
prevent perturbations by excess endogenous CaM. This
can be done by computationally designing complemen-
tary bumps and holes in peptides and CaM, respectively
(Palmer et al., 2006). Alternatively, CaM can be replaced
by other Ca2+-sensitive proteins, including Troponin-C
(Heim and Griesbeck, 2004; Mank et al., 2006) and
Ecad, in novel biosensor constructs. In particular, the
extracellular protein Ecad may not be susceptible to
perturbations by cytoplasmic proteins in vivo. Ecad is a
member of the Cadherin superfamily of Ca2+-dependent
cell-cell adhesion transmembrane glycoproteins. Struc-
turally, Ecad has three major regions: a cytoplasmic
domain, a transmembrane domain, and an extracellular520 Structure 15, 515–523, May 2007 ª2007 Elsevier Ltd All rigdomain facilitating cell-cell adhesion. This extracellular
region contains a tandem of five autonomously folding
repeats of 100 amino acid residues. In the absence of
Ca2+, the extracellular region is floppy. In the presence
of Ca2+, linkers between two consecutive repeats bind
three Ca2+ ions, which induces a conformational change
in which the linkers become rigid and the repeats form ho-
modimers (Alattia et al., 1999; Nagar et al., 1996).
Computational modeling with this class of FRET Ca2+
biosensors containing extracellular Ecad repeats
predicted that the FRET efficiency should increase. The
CEcad12Y and CEcad23Y biosensors were created and
consisted of Ecad repeats 1–2 and 2–3 flanked by a CFP
donor and YFP acceptor, respectively. Based on the
solved atomic structure of Ecad repeats 1–2, FPMOD
was used to generate models corresponding to the
CEcad12Y biosensor before and after Ca2+ induction. To
simulate the FRET efficiency change of the biosensor,
FRET efficiency values were compared between the free
and bound models. FPMOD predicted an increase from
3.1% to 4.5% in FRET efficiency upon binding of Ca2+,
which is an emission-ratio increase of 3.6% (Table 1).
This is consistent with the in vitro finding that there was
an increase in FRET emission ratio of 14% (Figure 2).
Although simulations were not done for CEcad23Y due
to the lack of a solved atomic structure for Ecad repeats
2–3, we suspect that it would behave similarly to
CEcad12Y, as the structures are very similar. The FPMOD
prediction of an increase in emission ratio for CEcad12Y is
also consistent with the in vitro experimental increase of
13% for CEcad23Y. In addition, the counterintuitive find-
ing that the distance shortened upon Ca2+ binding was
also confirmed. After binding Ca2+, the linker between
Ecad repeats 1 and 2 becomes rigid and extended, sug-
gesting a larger distance factor, and hence a lower FRET
efficiency. However, simulated FRET efficiency values
showed the opposite effect. Closer inspection of the
bound models revealed that homodimerization of the
bound case favored a shorter distance between the re-
strained CFP and YFP than the unbound case (91 A˚ and
85 A˚, respectively). Homodimerization limits the rotational
freedom of the biosensor models, as evident by the lower
orientation values (from 0.59 to 0.39), and forces a closer
distance between the CFP donor and YFP acceptor.
These Ecad biosensor models generated by using
FPMOD were capable of making nonintuitive predictions
and were used to reveal the underlying mechanisms of
the biosensor’s conformational change.
In this paper, we have shown that FPMOD is an effective
computational tool for the development and improvement
of FRET biosensors. While it is difficult to determine the
exact relationship between changes in FRET efficiency
and emission ratio, the values should be directly propor-
tional. FPMOD was used to evaluate the FRET efficiency
and emission-ratio changes for both new and existing
Ca2+ biosensor designs. For the YMLCKpC-CaM and
YCKKpC-CaM biosensors, it showed that the former
had an increase in FRET efficiency after Ca2+ induction,
while the latter had a decrease. For existing biosensors,hts reserved
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Ways & MeansYC6.1 and YC2.1, it showed that the larger dynamic range
of the YC6.1 biosensor was predictable. Furthermore, it
showed that the larger dynamic range of particular
YC2.1 biosensors with cpVenus acceptors was also
predictable. Lastly, it was used to design a class of Ca2+
biosensors (named CEcad12Y and CEcad23Y) based on
epithelial Cadherin repeats, which showed an increase in
FRET efficiency. All of these predictions were qualitatively
validated with experimental data from our group and
others. Therefore, this same approach can be applied to
designing new biosensors whose protein structures as
well as conformational changes due to specific bioactiv-
ities are known.
Further improvements to FPMOD might include a con-
sideration of the effects of van der Waals interactions,
electrostatic forces, and restricted dihedral angles on
the conformational space. The inclusion of other effects,
including heterodimerization of CFP and YFP, protein-
protein docking statistical potentials, and solvation effects
would further eliminate nonoptimal conformations,
which would allow a better quantitative correlation be-
tween simulation and experimental results. Alternatively,
experimental results could also be further refined through
the use of anisotropy studies. Further studies are also
required to determine the precise relationship between
simulation FRET efficiency and experimental emission
spectra.
Experimental Procedures
Calculating FRET Efficiency
E%=
R60
R60 +R
6
; (1)
R0 = 9:78310
33

Qdk
2n4J
1
6A; (2)
k2 = ðsin½qDsin½qA cos½f  2cos½qDcos½qA Þ2: (3)
FRET efficiency (E%) is the percentage of energy transferred be-
tween a donor-acceptor fluorophore pair. This efficiency is a function
of the Forster distance factor, Ro, the distance between the fluoro-
phores, R, and the orientation factor, k2. In turn, the orientation factor
depends on the angle between donor or acceptor fluorophore dipoles
and the joining vector (qA and qD, respectively), as well as the angle be-
tween fluorophore pair planes (f). A common assumed constant for k2
is 2/3, but this does not apply here because the linkers within the bio-
sensors are not in isotropic motion upon Ca2+ binding (Dale et al.,
1979; Hillel and Wu, 1976). Several relevant parameters are constants
defined for the donor-acceptor pair used in the biosensor. For CFP and
YFP, these constants are quantum yield (QD = 0.42), refractive index
(n = 1.4), and overlap integral (J = 14,618e13). The orientation of tran-
sition dipoles is defined with respect to PDB atom coordinates of the
HETATM for CFP and YFP, from atom N15 to C4 and atom N3 to
CZ, respectively. This assumed direction is kept consistent for all
constructs simulated. For each conformation, the dipoles and related
angles were determined from the PDB files and are used in Equations
1–3 to determine R, k2, and E%.
Calculating the Emission Ratio from FRET Efficiency
E%=
FD  FDA
FD
=
FNET
FNET +FDA
; (4)Structure 15,ðFD  FDAÞ
QC
=
SE
QY
; (5)
SE =FA;FRET  FA;CFP-OV  FA;CFP-EX ; (6)
FA;CFP-OV =nCFPFDA; (7)
EmR=
FA;FRET
FDA
; (8)
EmR=
nCFP  nCFPE% 

QY=QC

E%
E%  1 : (9)
A means of determining the FRET emission ratio from FRET effi-
ciency has been developed previously by using Equations 4–6, where
FD is the donor CFP emission in the absence of the acceptor YFP, FDA
is the donor CFP emission in the presence of the acceptor YFP, FNET is
the net FRET signal, SE is the sensitized YFP emission due to FRET,
QC is the quantum efficiency of the CFP donor, and QY is the quantum
efficiency of the YFP acceptor (Chen et al., 2005; Miyawaki and Tsien,
2000). Starting from these equations, we defined Equations 7–9 to cal-
culate the emission ratio (EmR) from FRET efficiency values obtained
through simulation. The sensitized YFP emission due to FRET, SE, is
the total raw FRET signal (FA,FRET) minus the overlap of donor emission
with the acceptor emission (FA,CFP-OV) and the acceptor emission due
to direct excitation at the donor wavelength (FA,CFP-EX). Given the 1:1
stoichiometry of CFP:YFP on these biosensors, the contribution of
FA,CFP-EX is negligible. In addition, nCFP is a spectral characteristic of
the known shape of the CFP emission spectrum, where the contribu-
tion of the donor emission spectrum is roughly 0.7 of the total donor
emission in the presence of the acceptor YFP. Qy and QC are 0.76
and 0.42, respectively (Griesbeck et al., 2001).
Constructing a FRET Biosensor Model
Given the solved atomic structure of each domain of the biosensor
(such as CFP, YFP, and the sensory proteins) in standard PDB format,
FRET biosensor models are constructed by joining each domain with
flexible linkers. Three subroutines of FPMOD are involved: residue in-
sertion, residue deletion, and domain fusion. Residue insertion is used
for adding linker residues. These linker residues are often introduced
either from restriction enzyme sites used in the subcloning process
or from the design process when it is desirable to lengthen the linkers
for greater conformational freedom. In contrast, residue deletion is
used to remove portions of the PDB file not required for the FRET bio-
sensor model. After protein domains are necessarily truncated and
linker residues are added, domain fusion is used to fuse the different
domains and their linkers together.
Sampling of the Conformational Space of a FRET
Biosensor Model
Once the FRET biosensor model is constructed, subroutines of
FPMOD are then used to sample its conformational space. All domains
of the FRET biosensor are treated as rigid bodies and are rotated
around their flexible linkers. These flexible linkers are located between
domains and do not form any secondary structures. For each residue
in a linker, there are three torsional or dihedral angles, c, F, and u.
During rotation, all linker residues are randomly rotated such that all
atoms of a linker residue preceding the N atom along the N-Ca bond
are rotated by the torsional angle F. Next, all atoms after the C atom
along the Ca-C bond are rotated by angle c. While the angles c and
F do not have any restriction, and thus range from 180 to 180, u
is fixed at 180. This is a reasonable restriction since the trans config-
uration is most commonly found in nature. After all residues in the flex-
ible linkers are randomly rotated and steric collisions are checked for,
this corresponds to one possible conformation of the fusion protein.
This model is then saved in PDB format, and the linker residue rotation
process is repeated again until a representative number of models are
generated to sufficiently span the conformational space. Tabulated
values are averages over all possible conformations generated. The515–523, May 2007 ª2007 Elsevier Ltd All rights reserved 521
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cient when doubling the number of models generated did not change
the overall average obtained. In all of our tested cases, averages were
calculated for 130 generated models.
Development of FPMODGui
To simplify the execution of FPMOD subroutines, a graphical user
interface called FPMODGui was developed. It includes the following
features: custom dialog boxes for each subroutine to ensure that the
user will enter the necessary arguments, a Command History window
to allow users to easily run recently used programs without having to
retype the arguments, and an output window for viewing results.
FPMODGui was developed by using the wxWindows toolkit and
involved creating derived classes specific to FPMOD programs from
generic classes found in the toolkit.
Constructing the YCKKpC-CaM and YMLCKpC-CaM Plasmids
Using the cassette-based technology described by Truong et al.
(2003), the plasmids for expressing the YCKKpC-CaM and YMLCKpC-
CaM biosensors were created with the combination of the plasmids
pCFPtx (Truong et al., 2003), pYFPtx (Truong et al., 2003), pCKKtx,
pMLCKtx, and pCaMtx. The latter three plasmids were created by,
first, amplification from cDNA libraries and digestion with SpeI and
XhoI. The fragments were then ligated into the SpeI and XhoI sites of
pTriEx-3 (Novagen) to create the pCKKtx, pMLCKtx, and pCaMtx
vectors, respectively. To construct the pYCKKpC-CaMtx and
pYMLCKpC-CaMtx plasmids, three steps were involved. First, pCFPtx
was digested with NcoI and NheI sites and then ligated into the NcoI
and SpeI sites of pCaMtx to create the intermediate pCFP-CaMtx vec-
tor. Then, pYFPtx was digested with NcoI and NheI sites and ligated
into the NcoI and SpeI sites of each of the pCKKtx and pMLCKtx vec-
tors to create the intermediate vectors, pYFP-CKKtx and pYFP-
MLCKtx, respectively. Finally, the pCFP-CaMtx vector was digested
with SpeI and XhoI and then ligated into the NheI and XhoI sites of
each of the pYFP-CKKtx and pYFP-MLCKtx vectors to create the final
plasmids, pYCKKpC-CaMtx and pYMLCKpC-CaMtx, respectively.
E. coli cells were transformed with these plasmids and were plated.
A colony fluorescing both cyan and yellow was selected.
Constructing the CEcad12Y and CEcad23Y Plasmids
The plasmids for expressing CEcad12Y and CEcad23Y biosensors
(pC12Ytx and pC23Ytx, respectively) were created with the combina-
tion of the following two plasmids: pCFPtx (Truong et al., 2003) and
pCfvtx (Truong et al., 2003). To create the C12Y and C23Y biosensors,
first the Ecad12 and Ecad23 fragments were amplified from cDNA li-
braries (Spring Bioscience) digested with SpeI-BglII and ligated into
the SpeI-BglII sites of pCfvtx to construct the intermediate plasmids
pEcad12Vtx and pEcad23Vtx. Finally, the pCFPtx plasmid was
digested with NcoI-NheI and ligated into the NcoI-SpeI sites of
pEcad12Vtx and pEcad23Vtx to construct the pC12Ytx and pC23Ytx
plasmids, respectively. E. coli cells were transformed with pC12Ytx
and pC23Ytx, and a single colony with both cyan and yellow fluores-
cence was selected.
Fluorescence Spectroscopy
Emission spectra of the biosensor constructs before and after Ca2+
saturation were recorded with a spectrophotometer (Shimadzu
RF-5301PC) with an excitation wavelength of 440 nm. From the emis-
sion spectra, the biosensors displayed a CFP emission peak of 477 ±
1 nm and a YFP emission peak of 523 ± 1 nm.
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